Prevalence of metallo-β-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii isolated from burn wounds and in vitro activities of antibiotic combinations against these isolates
- 30 September 2005
- journal article
- Published by Elsevier BV in Clinical Dermatology and Surgery
- Vol. 31 (6), 707-710
- https://doi.org/10.1016/j.burns.2005.02.017
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Comparison of the double-disk, combined disk, and Etest methods for detecting metallo-β-lactamases in gram-negative bacilliDiagnostic Microbiology and Infectious Disease, 2004
- Aerobic bacterial isolates from burn wound infections and their antibiograms—a five-year studyBurns, 2004
- Prevalence and characterization of metallo-β-lactamases in clinical isolates of pseudomonas aeruginosa☆Diagnostic Microbiology and Infectious Disease, 2004
- Results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme: report of the 2001 data from 15 United States medical centresInternational Journal of Antimicrobial Agents, 2004
- Prevalence of metallo-β-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii in a Korean University hospital and comparison of screening methods for detecting metallo-β-lactamaseJournal of Microbiological Methods, 2003
- Infections in a burn intensive care unit: experience of seven yearsJournal of Hospital Infection, 2003
- Imipenem-EDTA Disk Method for Differentiation of Metallo-β-Lactamase-Producing Clinical Isolates of Pseudomonas spp. and Acinetobacter sppJournal of Clinical Microbiology, 2002
- bla VIM-2 Cassette-Containing Novel Integrons in Metallo-β-Lactamase-Producing Pseudomonas aeruginosa and Pseudomonas putida Isolates Disseminated in a Korean HospitalAntimicrobial Agents and Chemotherapy, 2002
- Convenient Test for Screening Metallo-β-Lactamase-Producing Gram-Negative Bacteria by Using Thiol CompoundsJournal of Clinical Microbiology, 2000
- Investigation of the synergic effects of aminoglycoside-fluoroquinolone and third-generation cephalosporin combinations against clinical isolates of Pseudomonas spp.Journal of Antimicrobial Chemotherapy, 1999